股本结构
单位：万股
| 公告日期 | 2025-01-21 | 2025-04-29 | 2024-12-10 | 2024-11-07 | 2024-08-23 | 2021-11-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 799.45 | 790.20 | 790.20 | 504.20 | 493.84 | 488.25 |
| 普通股本 | 799.45 | 790.20 | 790.20 | 504.20 | 493.84 | 488.25 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-01-21 | 2024-12-31 | 2024-12-11 | 2024-10-15 | 2024-06-30 | 2021-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：1
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-01-21 | 799.45 | 未披露 | 定期报告 | 2025-01-21 |
| 2025-04-29 | 790.20 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of common stock from public offering
Issuance of common stock from stock option exercises
|
2024-12-31 |
| 2024-12-10 | 790.20 | 未披露 |
更多>>
ADSs Offered 2,860,000 ADSs by the company, Each ADS represents one common share
|
2024-12-11 |
| 2024-11-07 | 504.20 | 未披露 | 定期报告 | 2024-10-15 |
| 2024-08-23 | 493.84 | 未披露 | 定期报告 | 2024-06-30 |
| 2021-11-08 | 488.25 | 未披露 | 定期报告 | 2021-06-30 |
| 2021-02-02 | 488.25 | 未披露 |
更多>>
1.MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) announced today that it has completed the sale of an additional 60,000 ADSs (each ADS representing one common share, no par value) at the public offering price of US$15.00 per ADS, pursuant to the exercise by the underwriter of the over-allotment option granted to it in connection with the Company’s initial public offering. The Company expects to receive additional net proceeds of approximately US$837,000, after underwriting discounts and commissions.
|
2021-02-01 |
| 2021-05-17 | 482.25 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock upon initial public offering, net of offering costs and tax
|
2020-12-31 |
| 2020-12-30 | 482.25 | 未披露 |
更多>>
1.ADSs offered by the company 800,000 ADSs.
|
2020-12-29 |
From December 31, 2023 to December 31, 2024
Issuance of common stock from public offering
Issuance of common stock from stock option exercises
ADSs Offered 2,860,000 ADSs by the company, Each ADS represents one common share
1.MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM) announced today that it has completed the sale of an additional 60,000 ADSs (each ADS representing one common share, no par value) at the public offering price of US$15.00 per ADS, pursuant to the exercise by the underwriter of the over-allotment option granted to it in connection with the Company’s initial public offering. The Company expects to receive additional net proceeds of approximately US$837,000, after underwriting discounts and commissions.
From December 31, 2019 to December 31, 2020
Issuance of common stock upon initial public offering, net of offering costs and tax
1.ADSs offered by the company 800,000 ADSs.